Ulf Wiinberg - 01 Dec 2022 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Issuer symbol
INKT
Transactions as of
01 Dec 2022
Net transactions value
+$14,000
Form type
4
Filing time
05 Dec 2022, 17:27:16 UTC
Previous filing
05 Oct 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Award $14,000 +5,364 +17% $2.61 36,052 01 Dec 2022 Direct F1, F2
holding INKT Common Stock 278,300 01 Dec 2022 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
F2 Includes shares inadvertently excluded from a Form 4 filed on September 19, 2022.
F3 Shares are held in an irrevocable trust for the benefit of Mr. Wiinberg's family. The indirectly owned shares were inadvertently excluded from a Form 4 filed on September 19, 2022.